DE69127829D1 - Expression von pace in wirtszellen und verfahren zu dessen verwendung - Google Patents
Expression von pace in wirtszellen und verfahren zu dessen verwendungInfo
- Publication number
- DE69127829D1 DE69127829D1 DE69127829T DE69127829T DE69127829D1 DE 69127829 D1 DE69127829 D1 DE 69127829D1 DE 69127829 T DE69127829 T DE 69127829T DE 69127829 T DE69127829 T DE 69127829T DE 69127829 D1 DE69127829 D1 DE 69127829D1
- Authority
- DE
- Germany
- Prior art keywords
- pace
- expression
- host cells
- amino acid
- sequence encoding
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Lifetime
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
- C12N9/14—Hydrolases (3)
- C12N9/48—Hydrolases (3) acting on peptide bonds (3.4)
- C12N9/50—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25)
- C12N9/64—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25) derived from animal tissue
- C12N9/6421—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25) derived from animal tissue from mammals
- C12N9/6424—Serine endopeptidases (3.4.21)
- C12N9/6454—Dibasic site splicing serine proteases, e.g. kexin (3.4.21.61); furin (3.4.21.75) and other proprotein convertases
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/745—Blood coagulation or fibrinolysis factors
- C07K14/755—Factors VIII, e.g. factor VIII C (AHF), factor VIII Ag (VWF)
Applications Claiming Priority (5)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US62109290A | 1990-11-26 | 1990-11-26 | |
US62144390A | 1990-11-29 | 1990-11-29 | |
US62085990A | 1990-11-29 | 1990-11-29 | |
US62145790A | 1990-11-30 | 1990-11-30 | |
PCT/US1991/008725 WO1992009698A1 (en) | 1990-11-26 | 1991-11-26 | Expression of pace in host cells and methods of use thereof |
Publications (2)
Publication Number | Publication Date |
---|---|
DE69127829D1 true DE69127829D1 (de) | 1997-11-06 |
DE69127829T2 DE69127829T2 (de) | 1998-03-19 |
Family
ID=27505162
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
DE69127829T Expired - Lifetime DE69127829T2 (de) | 1990-11-26 | 1991-11-26 | Expression von pace in wirtszellen und verfahren zu dessen verwendung |
Country Status (10)
Country | Link |
---|---|
US (3) | US5460950A (de) |
EP (2) | EP0574402B2 (de) |
JP (2) | JP4236698B2 (de) |
AT (1) | ATE158816T1 (de) |
CA (1) | CA2096418C (de) |
DE (1) | DE69127829T2 (de) |
DK (1) | DK0574402T3 (de) |
ES (1) | ES2109336T3 (de) |
IE (1) | IE914102A1 (de) |
WO (1) | WO1992009698A1 (de) |
Families Citing this family (114)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5935815A (en) * | 1989-10-25 | 1999-08-10 | Katholieke Universiteit Leuven | Process for micro biological production of proteins |
WO1992009698A1 (en) * | 1990-11-26 | 1992-06-11 | Genetics Institute, Inc. | Expression of pace in host cells and methods of use thereof |
US5965789A (en) * | 1991-01-11 | 1999-10-12 | American Red Cross | Engineering protein posttranslational modification by PACE/furin in transgenic non-human mammals |
US6348327B1 (en) * | 1991-12-06 | 2002-02-19 | Genentech, Inc. | Non-endocrine animal host cells capable of expressing variant proinsulin and processing the same to form active, mature insulin and methods of culturing such cells |
JPH07504818A (ja) | 1992-03-09 | 1995-06-01 | カイロン コーポレイション | 細胞内pace4およびpace4.1遺伝子ならびにポリペプチドに関する組成物および方法 |
US5846802A (en) * | 1992-04-15 | 1998-12-08 | Buxton; Frank | Fungal Protease |
US6277975B1 (en) | 1992-10-23 | 2001-08-21 | Genetics Institute, Inc. | Fusions of P-selectin ligand protein and polynucleotides encoding same |
CA2147623C (en) | 1992-10-23 | 2005-05-03 | Glenn R. Larsen | Novel p-selectin ligand protein |
US5604201A (en) * | 1993-01-08 | 1997-02-18 | State Of Oregon, Acting By And Through The Oregon State Board Of Higher Education On Behalf Of The Oregon Health Sciences University, A Non-Profit Organization | Methods and reagents for inhibiting furin endoprotease |
JPH11500920A (ja) * | 1995-02-27 | 1999-01-26 | アボツト・ラボラトリーズ | 修飾された組換えタンパク質を細菌系において発現させるプラスミド |
EP0812361A1 (de) * | 1995-02-27 | 1997-12-17 | Abbott Laboratories | Verfahren zur expression von modifizierten rekombinanten proteinen in einem bakteriellen system |
US5807702A (en) * | 1995-02-27 | 1998-09-15 | Abbott Laboratories | Method for expressing phosphorylated recombinant human β-casein in a bacterial system |
US5710044A (en) * | 1995-02-27 | 1998-01-20 | Abbott Laboratories | Plasmid for expressing phosphorylated recombinant proteins in a bacterial system |
US5942254A (en) * | 1995-02-27 | 1999-08-24 | Abbott Laboratories | Phosphorylated recombinant human β-casein expressed in a bacterial system |
AT404838B (de) | 1995-11-24 | 1999-03-25 | Immuno Ag | Herstellung von proteinen aus pro-proteinen durch fusionsproteine abgeleitet von furin oder furinanalogen |
JPH09295945A (ja) * | 1996-04-30 | 1997-11-18 | Hoechst Yakuhin Kogyo Kk | 成熟型骨誘導因子の製造方法 |
US6518411B1 (en) * | 1996-11-22 | 2003-02-11 | University Of Iowa | RGS compositions and therapeutic and diagnostic uses therefor |
AT405517B (de) | 1997-02-27 | 1999-09-27 | Immuno Ag | Faktor x-deletionsmutanten und analoge davon |
AT405516B (de) * | 1997-02-27 | 1999-09-27 | Immuno Ag | Faktor x-analoge mit modifizierter proteasespaltstelle |
GB9704305D0 (en) * | 1997-03-01 | 1997-04-23 | Univ Manchester | Procollagen assembly |
US6153420A (en) * | 1997-04-24 | 2000-11-28 | Zymogenetics, Inc. | Serine protease polypeptides and materials and methods for making them |
US7081519B1 (en) | 1997-04-24 | 2006-07-25 | Zymogenetics, Inc. | Antibodies to serine protease polypeptides |
KR20010012280A (ko) * | 1997-05-06 | 2001-02-15 | 리스 데브라 케이. | 인간의 프로호르몬 변환효소 4 |
US7247708B2 (en) | 1997-10-23 | 2007-07-24 | Regents Of The University Of Minnesota | Modified vitamin K-dependent polypeptides |
US6747003B1 (en) * | 1997-10-23 | 2004-06-08 | Regents Of The University Of Minnesota | Modified vitamin K-dependent polypeptides |
US6642011B2 (en) * | 1998-04-15 | 2003-11-04 | Genencor International, Inc. | Human protease and use of such protease for pharmaceutical applications and for reducing the allergenicity of non-human proteins |
CA2249648A1 (en) * | 1998-11-04 | 2000-05-04 | Nabil G. Seidah | Mammalian subtilisin/kexin isozyme ski-1: a proprotein convertase with a unique cleavage specificity |
WO2000028065A1 (en) * | 1998-11-06 | 2000-05-18 | Novo Nordisk A/S | Method for the production of fvii |
AT410216B (de) | 1999-08-10 | 2003-03-25 | Baxter Ag | Faktor x-analogon mit verbesserter aktivierbarkeit |
US6511832B1 (en) * | 1999-10-06 | 2003-01-28 | Texas A&M University System | In vitro synthesis of capped and polyadenylated mRNAs using baculovirus RNA polymerase |
ES2310527T3 (es) * | 1999-11-19 | 2009-01-16 | Solvay Pharmaceuticals B.V. | Enzimas humanas de la familia de las metaloproteasas. |
DK1257295T3 (da) * | 2000-02-11 | 2009-08-10 | Bayer Healthcare Llc | Faktor VII eller VIIA-lignende molekyler |
US7220837B1 (en) | 2000-04-28 | 2007-05-22 | Regents Of The University Of Minnesota | Modified vitamin K-dependent polypeptides |
US7812132B2 (en) * | 2000-04-28 | 2010-10-12 | Regents Of The University Of Minnesota | Modified vitamin K-dependent polypeptides |
US20040047853A1 (en) * | 2000-06-09 | 2004-03-11 | Dahl Soren W | Purified proenzyme of dipeptidyl peptidase i (pro-dppi) |
US6596526B1 (en) * | 2000-06-09 | 2003-07-22 | Baxter Aktiengesellschaft | Furin polypeptides with improved characteristics |
US20030211094A1 (en) * | 2001-06-26 | 2003-11-13 | Nelsestuen Gary L. | High molecular weight derivatives of vitamin k-dependent polypeptides |
BR0114373A (pt) * | 2000-10-02 | 2004-02-17 | Novo Nordisk As | Célula hospedeira eucariótica, métodos para a produção de fvii e de fviia ou de suas variantes, de uma proteìna dependente de vitamina k e de uma célula hospedeira eucariótica produtora de fvii ou de seu análogo, vetor recombinante, fvii e fviia recombinante ou suas variantes, e, proteìna dependente de vitamina k recombinante |
AU2002225681A1 (en) * | 2000-11-15 | 2002-05-27 | Globe Immune, Inc. | Yeast-dentritic cell vaccines and uses thereof |
BR0209855A (pt) * | 2001-05-18 | 2004-06-15 | Solvay Pharm Gmbh | Uso de compostos com atividade inibidora de nep/mp combinada na preparação de medicamentos |
US20040143104A1 (en) * | 2001-08-08 | 2004-07-22 | Wadsworth Samuel C. | Methods of treating diabetes and other blood sugar disorders |
JP2005509409A (ja) * | 2001-08-08 | 2005-04-14 | ジェンザイム・コーポレーション | 糖尿病および他の血糖疾患の治療方法 |
DK1499719T3 (da) | 2002-04-30 | 2011-02-28 | Bayer Healthcare Llc | Faktor VII- eller VIIa-polypeptidvarianter |
AU2003241599A1 (en) * | 2002-05-22 | 2003-12-12 | The Children's Hospital Of Philadelphia | Compositions and methods for the treatment of hemophilia a |
WO2004083361A2 (en) * | 2003-03-20 | 2004-09-30 | Maxygen Holdings Ltd. | FVII OR FVIIa VARIANTS |
TWI353991B (en) | 2003-05-06 | 2011-12-11 | Syntonix Pharmaceuticals Inc | Immunoglobulin chimeric monomer-dimer hybrids |
AU2004247799B2 (en) * | 2003-06-19 | 2009-12-03 | Bayer Healthcare Llc | Factor VII or VIIa Gla domain variants |
DK2380985T3 (en) | 2003-09-23 | 2014-03-17 | Univ North Carolina | Cells expressing the vitamin K epoxide reductase, as well as their use |
US20050107318A1 (en) * | 2003-11-17 | 2005-05-19 | Samuel Wadsworth | Methods of treating diabetes and other blood sugar disorders |
US20050196864A1 (en) * | 2004-02-10 | 2005-09-08 | Goldman Steven A. | Induction and high-yield preparative purification of mesencephalic dopaminergic neuronal progenitor cells and dopaminergic neurons from human embryonic stem cells |
US20060003958A1 (en) * | 2004-05-11 | 2006-01-05 | Melville Mark W | Novel polynucleotides related to oligonucleotide arrays to monitor gene expression |
JP2008505119A (ja) | 2004-06-30 | 2008-02-21 | ネクター セラピューティクス アラバマ,コーポレイション | 高分子−第ix因子部分の抱合体 |
EP1789096A4 (de) * | 2004-09-07 | 2009-07-08 | Archemix Corp | Aptamere für den von-willebrand-faktor und ihre verwendung als therapeutika für thrombotische erkrankungen |
KR20070101226A (ko) * | 2004-09-07 | 2007-10-16 | 아케믹스 코포레이션 | 앱타머의 약화학 |
US7566701B2 (en) * | 2004-09-07 | 2009-07-28 | Archemix Corp. | Aptamers to von Willebrand Factor and their use as thrombotic disease therapeutics |
US20090325226A1 (en) | 2005-03-15 | 2009-12-31 | Stafford Darrel W | Methods and Compositions for Producing Active Vitamin K-Dependent Proteins |
US9238150B2 (en) | 2005-07-22 | 2016-01-19 | The Board Of Trustees Of The Leland Stanford Junior University | Optical tissue interface method and apparatus for stimulating cells |
US20090093403A1 (en) | 2007-03-01 | 2009-04-09 | Feng Zhang | Systems, methods and compositions for optical stimulation of target cells |
US8926959B2 (en) | 2005-07-22 | 2015-01-06 | The Board Of Trustees Of The Leland Stanford Junior University | System for optical stimulation of target cells |
US9274099B2 (en) | 2005-07-22 | 2016-03-01 | The Board Of Trustees Of The Leland Stanford Junior University | Screening test drugs to identify their effects on cell membrane voltage-gated ion channel |
US9278159B2 (en) | 2005-07-22 | 2016-03-08 | The Board Of Trustees Of The Leland Stanford Junior University | Light-activated cation channel and uses thereof |
US10052497B2 (en) | 2005-07-22 | 2018-08-21 | The Board Of Trustees Of The Leland Stanford Junior University | System for optical stimulation of target cells |
JP5526332B2 (ja) * | 2005-12-21 | 2014-06-18 | シーエヌジェイ ホールディングス,インコーポレイテッド | 組み換え法によって生物活性ビタミンk依存性タンパク質を製造する方法 |
TWI428448B (zh) | 2006-03-24 | 2014-03-01 | Syntonix Pharmaceuticals Inc | 作為第九因子(factor ix)原肽處理酶之pc5 |
DE602006009631D1 (de) | 2006-05-10 | 2009-11-19 | Biocompatibles Uk Ltd | GLP-1 Peptide enthaltende kugelförmige Mikrokapseln, deren Produktion und deren Verwendung |
WO2008086470A1 (en) | 2007-01-10 | 2008-07-17 | The Board Of Trustees Of The Leland Stanford Junior University | System for optical stimulation of target cells |
US8401609B2 (en) | 2007-02-14 | 2013-03-19 | The Board Of Trustees Of The Leland Stanford Junior University | System, method and applications involving identification of biological circuits such as neurological characteristics |
CA3090908A1 (en) | 2007-04-26 | 2008-11-06 | Aptevo Biotherapeutics Llc | Recombinant vitamin k dependent proteins with high sialic acid content and methods of preparing same |
KR101660533B1 (ko) | 2007-05-22 | 2016-10-10 | 박스알타 인코퍼레이티드 | 인간 푸린의 분취 정제 방법 |
US20090203766A1 (en) * | 2007-06-01 | 2009-08-13 | Archemix Corp. | vWF aptamer formulations and methods for use |
US10434327B2 (en) | 2007-10-31 | 2019-10-08 | The Board Of Trustees Of The Leland Stanford Junior University | Implantable optical stimulators |
US10035027B2 (en) | 2007-10-31 | 2018-07-31 | The Board Of Trustees Of The Leland Stanford Junior University | Device and method for ultrasonic neuromodulation via stereotactic frame based technique |
SG10201503304RA (en) | 2007-12-27 | 2015-06-29 | Baxter Int | Cell culture processes |
PT2240578T (pt) | 2007-12-31 | 2019-06-19 | Baxalta GmbH | Furina recombinante substancialmente isenta de proteínas animais e métodos para a sua produção |
CA2722278C (en) | 2008-04-23 | 2020-03-31 | Feng Zhang | Systems, methods and compositions for optical stimulation of target cells |
MX2010012986A (es) | 2008-05-29 | 2011-05-25 | Univ Leland Stanford Junior | Linea de celulas, sistema y metodo para control optico de mensajeros secundarios. |
BRPI0915583A2 (pt) | 2008-06-17 | 2016-01-26 | Univ Leland Stanford Junior | aparelho e métodos para controle do desenvolvimento celular |
CA2728238C (en) | 2008-06-17 | 2019-03-12 | M. Bret Schneider | Methods, systems and devices for optical stimulation of target cells using an optical transmission element |
WO2010006049A1 (en) | 2008-07-08 | 2010-01-14 | The Board Of Trustees Of The Leland Stanford Junior University | Materials and approaches for optical stimulation of the peripheral nervous system |
EP2163243A1 (de) | 2008-09-12 | 2010-03-17 | Biocompatibles UK Limited | Behandlung akuter Herzinfarkte mithilfe eingekapselter Zellen, welche GLP-1-Peptide oder deren Analoga kodieren und absondern |
NZ602416A (en) | 2008-11-14 | 2014-08-29 | Univ Leland Stanford Junior | Optically-based stimulation of target cells and modifications thereto |
EP2251028A1 (de) | 2009-05-12 | 2010-11-17 | Biocompatibles Uk Ltd. | Behandlung von Augenerkrankungen unter Verwendung eingekapselter Zellen, die einen antiangiogenetischen Faktor und/oder einen neuroprotektiven Faktor codieren und sekretieren |
SG183899A1 (en) | 2010-03-17 | 2012-10-30 | Univ Leland Stanford Junior | Light-sensitive ion-passing molecules |
WO2012006623A1 (en) * | 2010-07-09 | 2012-01-12 | Biogen Idec Hemophilia Inc. | Systems for factor viii processing and methods thereof |
EA201291482A1 (ru) | 2010-07-09 | 2013-10-30 | Байоджен Айдек Хемофилия Инк. | Химерные факторы коагуляции |
EP2616096A1 (de) | 2010-09-15 | 2013-07-24 | Biocompatibles Uk Ltd. | Behandlung von gefässerkrankungen unter verwendung eingekapselter zellen, die glp-1 kodieren und sezernieren, oder eines fragments oder einer variante davon |
CN106106368A (zh) | 2010-11-05 | 2016-11-16 | 斯坦福大学托管董事会 | 光控cns功能障碍 |
US10086012B2 (en) | 2010-11-05 | 2018-10-02 | The Board Of Trustees Of The Leland Stanford Junior University | Control and characterization of memory function |
EP3225108A1 (de) | 2010-11-05 | 2017-10-04 | The Board of Trustees of The Leland Stanford Junior University | Optogenetische steuerung eines verhaltens in zusammenhang mit belohnungen |
ES2684307T3 (es) | 2010-11-05 | 2018-10-02 | The Board Of Trustees Of The Leland Stanford Junior University | Proteínas estabilizadas de tipo opsina de función escalonada y métodos de uso de las mismas |
CN106422081B (zh) | 2010-11-05 | 2019-06-21 | 斯坦福大学托管董事会 | 用于光遗传学方法的光的上转换 |
EP3486253A1 (de) | 2010-11-05 | 2019-05-22 | The Board of Trustees of The Leland Stanford Junior University | Lichtaktivierte chimäre opsine und verwendungsverfahren dafür |
US8696722B2 (en) | 2010-11-22 | 2014-04-15 | The Board Of Trustees Of The Leland Stanford Junior University | Optogenetic magnetic resonance imaging |
WO2012088222A2 (en) | 2010-12-21 | 2012-06-28 | The University Of North Carolina At Chapel Hill | Methods and compositions for producing active vitamin k-dependent proteins |
BR112013023167A2 (pt) * | 2011-03-11 | 2016-09-06 | Univ São Paulo | método para produção do fator viii humano recombinante, fator viii humano recombinante, produto farmacêutico, uso do fator viii humano recombinante, método para tratamento de doenças relacionadas à diminuição, inativação ou ausência de fator viii, uso da endoprotease spc6 e/ou da pace4 ai e/ou da pacesol e processamento proteolítico do fator viii humano recombinante |
AR086672A1 (es) | 2011-06-02 | 2014-01-15 | Baxter Int | Formulaciones de furina recombinante |
CA2859364C (en) | 2011-12-16 | 2019-05-07 | The Board Of Trustees Of The Leland Stanford Junior University | Opsin polypeptides and methods of use thereof |
CN104254603A (zh) * | 2012-02-14 | 2014-12-31 | 博尔托拉制药公司 | 用于制备xa因子抑制剂的重组解毒剂的方法 |
CA2865296A1 (en) | 2012-02-21 | 2013-08-29 | Karl A. DEISSEROTH | Compositions and methods for treating neurogenic disorders of the pelvic floor |
CA2875247A1 (en) | 2012-06-08 | 2013-12-12 | Biogen Idec Ma Inc. | Chimeric clotting factors |
JP2015521589A (ja) | 2012-06-08 | 2015-07-30 | バイオジェン・エムエイ・インコーポレイテッドBiogen MA Inc. | プロコアグラント化合物 |
CA2899089C (en) | 2013-03-15 | 2021-10-26 | Biogen Ma Inc. | Factor ix polypeptide formulations |
EP2968997B1 (de) | 2013-03-15 | 2019-06-26 | The Board of Trustees of the Leland Stanford Junior University | Optogenetische steuerung des verhaltenszustandes |
US9636380B2 (en) | 2013-03-15 | 2017-05-02 | The Board Of Trustees Of The Leland Stanford Junior University | Optogenetic control of inputs to the ventral tegmental area |
WO2014179331A2 (en) | 2013-04-29 | 2014-11-06 | The Board Of Trustees Of The Leland Stanford Junior University | Devices, systems and methods for optogenetic modulation of action potentials in target cells |
WO2015023782A1 (en) | 2013-08-14 | 2015-02-19 | The Board Of Trustees Of The Leland Stanford Junior University | Compositions and methods for controlling pain |
KR102245264B1 (ko) | 2014-05-26 | 2021-04-28 | 아카데미슈 지켄후이스 라이덴 | 출혈 치료를 위한 프로혈액응고 단백질 |
TWI666319B (zh) * | 2014-08-12 | 2019-07-21 | 美商巴克斯歐塔公司 | 在分泌furin之哺乳動物表現系統中生產經完全加工且具功能性之因子X |
JP7095990B2 (ja) | 2014-09-18 | 2022-07-05 | シーダーズ-サイナイ メディカル センター | 線維症を治療するための組成物及び方法 |
MA40835A (fr) | 2014-10-23 | 2017-08-29 | Biogen Ma Inc | Anticorps anti-gpiib/iiia et leurs utilisations |
MA40861A (fr) | 2014-10-31 | 2017-09-05 | Biogen Ma Inc | Anticorps anti-glycoprotéines iib/iiia |
EP4194001A1 (de) | 2015-04-22 | 2023-06-14 | Cedars-Sinai Medical Center | Enterisch verabreichte bittere oligopeptide zur behandlung von typ-2-diabetes und fettleibigkeit |
US10568516B2 (en) | 2015-06-22 | 2020-02-25 | The Board Of Trustees Of The Leland Stanford Junior University | Methods and devices for imaging and/or optogenetic control of light-responsive neurons |
US11294165B2 (en) | 2017-03-30 | 2022-04-05 | The Board Of Trustees Of The Leland Stanford Junior University | Modular, electro-optical device for increasing the imaging field of view using time-sequential capture |
Family Cites Families (61)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DE2855719A1 (de) | 1978-12-22 | 1980-07-10 | Siemens Ag | Zahnaerztliche handstueckanordnung |
US4336336A (en) | 1979-01-12 | 1982-06-22 | President And Fellows Of Harvard College | Fused gene and method of making and using same |
US4399216A (en) | 1980-02-25 | 1983-08-16 | The Trustees Of Columbia University | Processes for inserting DNA into eucaryotic cells and for producing proteinaceous materials |
AU545912B2 (en) | 1980-03-10 | 1985-08-08 | Cetus Corporation | Cloned heterologous jive products in bacillies |
ZA811368B (en) | 1980-03-24 | 1982-04-28 | Genentech Inc | Bacterial polypedtide expression employing tryptophan promoter-operator |
US4419446A (en) | 1980-12-31 | 1983-12-06 | The United States Of America As Represented By The Department Of Health And Human Services | Recombinant DNA process utilizing a papilloma virus DNA as a vector |
NZ199722A (en) | 1981-02-25 | 1985-12-13 | Genentech Inc | Dna transfer vector for expression of exogenous polypeptide in yeast;transformed yeast strain |
BR8202422A (pt) | 1981-04-29 | 1983-04-12 | Biogen Nv | Vetor de clonacao de bacillus processo para sua construcao molecula de dna recombinante processo para sua construcao e processo para a producao de um polipeptidio |
US4551433A (en) | 1981-05-18 | 1985-11-05 | Genentech, Inc. | Microbial hybrid promoters |
US4652639A (en) * | 1982-05-06 | 1987-03-24 | Amgen | Manufacture and expression of structural genes |
CA1341302C (en) | 1983-02-22 | 2001-10-09 | Rae Lyn Burke | Yeast expression systems with vectors having gapdh or pyk promoters and synthesis of foreign protein |
US4876197A (en) | 1983-02-22 | 1989-10-24 | Chiron Corporation | Eukaryotic regulatable transcription |
JPS59166086A (ja) | 1983-03-09 | 1984-09-19 | Teruhiko Beppu | 新規な発現型プラスミドとそれらを用いて仔牛プロキモシン遺伝子を大腸菌内で発現させる方法 |
US4546083A (en) | 1983-04-22 | 1985-10-08 | Stolle Research & Development Corporation | Method and device for cell culture growth |
US4588684A (en) | 1983-04-26 | 1986-05-13 | Chiron Corporation | a-Factor and its processing signals |
JPS59205983A (ja) | 1983-04-28 | 1984-11-21 | ジエネツクス・コ−ポレイシヨン | 異種遺伝子を原核微生物で発現させる方法 |
US4663280A (en) | 1983-05-19 | 1987-05-05 | Public Health Research Institute Of The City Of New York | Expression and secretion vectors and method of constructing vectors |
US4745051A (en) * | 1983-05-27 | 1988-05-17 | The Texas A&M University System | Method for producing a recombinant baculovirus expression vector |
US4689406A (en) | 1983-08-10 | 1987-08-25 | Amgen | Enhancement of microbial expression of polypeptides |
US4870008A (en) | 1983-08-12 | 1989-09-26 | Chiron Corporation | Secretory expression in eukaryotes |
EP0136907A3 (de) | 1983-10-03 | 1986-12-30 | Genentech, Inc. | Xenogeneisches Expressionskontrollsystem, Verfahren zu dessen Verwendung, dieses enthaltende Expressionsvektoren, mit denselben transformierte Zellen und daraus hergestellte heterolose Proteine |
US4703008A (en) * | 1983-12-13 | 1987-10-27 | Kiren-Amgen, Inc. | DNA sequences encoding erythropoietin |
US4740461A (en) | 1983-12-27 | 1988-04-26 | Genetics Institute, Inc. | Vectors and methods for transformation of eucaryotic cells |
US4880734A (en) | 1984-05-11 | 1989-11-14 | Chiron Corporation | Eukaryotic regulatable transcription |
EP0164556B1 (de) | 1984-05-11 | 1994-03-02 | Chiron Corporation | Erhöhte Hefetranskription unter Verwendung einer Hybridkonstruktion der Promotorregion |
US5077204A (en) * | 1984-06-21 | 1991-12-31 | Chiron Corporation | Yeast endopeptidase for basic amino-acid site cleavage, preparation and use |
US4738921A (en) | 1984-09-27 | 1988-04-19 | Eli Lilly And Company | Derivative of the tryptophan operon for expression of fused gene products |
US4745056A (en) | 1984-10-23 | 1988-05-17 | Biotechnica International, Inc. | Streptomyces secretion vector |
US4837148A (en) | 1984-10-30 | 1989-06-06 | Phillips Petroleum Company | Autonomous replication sequences for yeast strains of the genus pichia |
US4683195A (en) | 1986-01-30 | 1987-07-28 | Cetus Corporation | Process for amplifying, detecting, and/or-cloning nucleic acid sequences |
US4683202A (en) | 1985-03-28 | 1987-07-28 | Cetus Corporation | Process for amplifying nucleic acid sequences |
ATE63757T1 (de) | 1985-03-28 | 1991-06-15 | Chiron Corp | Expression durch verwendung von fusionsgenen fuer proteinproduktion. |
GR860984B (en) * | 1985-04-17 | 1986-08-18 | Zymogenetics Inc | Expression of factor vii and ix activities in mammalian cells |
DE3684546D1 (de) * | 1985-04-22 | 1992-04-30 | Genetics Inst | Herstellung mit hoher leistung des aktivfaktors ix. |
US4865974A (en) | 1985-09-20 | 1989-09-12 | Cetus Corporation | Bacterial methionine N-terminal peptidase |
ES2061482T3 (es) | 1986-05-02 | 1994-12-16 | Gist Brocades Nv | Metodo para la identificacion de secuencias de señal secretora para sintesis de proteina extracelular en bacillus. |
EP0246709A1 (de) * | 1986-05-20 | 1987-11-25 | Stichting Katholieke Universiteit | Rekombinantes DNS, komplementäre DNS, Protein, Antikörper und Verfahren zum Nachweis von Tumorzellen |
US4959455A (en) | 1986-07-14 | 1990-09-25 | Genetics Institute, Inc. | Primate hematopoietic growth factors IL-3 and pharmaceutical compositions |
JP2612874B2 (ja) | 1986-10-02 | 1997-05-21 | マサチユセツツ・インスチチユート・オブ・テクノロジー | タンパク質の代謝的安定性を調節する方法 |
JPS63123383A (ja) | 1986-11-11 | 1988-05-27 | Mitsubishi Kasei Corp | ハイブリツドプロモ−タ−、発現調節dna配列および発現ベクタ− |
US4912040A (en) | 1986-11-14 | 1990-03-27 | Genetics Institute, Inc. | Eucaryotic expression system |
US4870023A (en) * | 1987-03-16 | 1989-09-26 | American Biogenetic Sciences, Inc. | Recombinant baculovirus occlusion bodies in vaccines and biological insecticides |
DK175243B1 (da) | 1987-03-23 | 2004-07-19 | Zymogenetics Inc | Ekspressionsvektor, der er i stand til at styre ekspression af heterologe gener eller cDNA i gær, gærværtscelle samt fremgangsmåde til öget produktion af proteiner i gærværtsceller |
GB8712540D0 (en) * | 1987-05-28 | 1987-07-01 | Ucb Sa | Expression of human proapolipoprotein a-i |
US4929553A (en) * | 1987-05-29 | 1990-05-29 | Canadian Patents & Development Ltd. | Protease for specific processing of secreted proteins |
US5041378A (en) * | 1987-08-11 | 1991-08-20 | Cetus Corporation | Procaryotic xylose isomerase muteins |
DK463887D0 (da) | 1987-09-07 | 1987-09-07 | Novo Industri As | Gaerleader |
US4929555A (en) | 1987-10-19 | 1990-05-29 | Phillips Petroleum Company | Pichia transformation |
US4992373A (en) * | 1987-12-04 | 1991-02-12 | Eli Lilly And Company | Vectors and compounds for direct expression of activated human protein C |
CA1340740C (en) * | 1987-12-08 | 1999-09-14 | Eileen R. Mulvihill | Co-expression in eukaryotic cells |
CA1340772C (en) | 1987-12-30 | 1999-09-28 | Patricia Tekamp-Olson | Expression and secretion of heterologous protiens in yeast employing truncated alpha-factor leader sequences |
US4973551A (en) | 1988-01-15 | 1990-11-27 | Merck & Co., Inc. | Vector for the expression of fusion proteins and protein immunogens |
JP2643968B2 (ja) * | 1988-02-03 | 1997-08-25 | サントリー株式会社 | Kex2エンドプロテアーゼ及びその製造方法 |
IL89790A (en) * | 1988-04-01 | 2002-05-23 | Johns Hopking University | Sequences of nucleic acids encoding and cells producing CR1 protein and methods for its production and purification |
US5004803A (en) * | 1988-11-14 | 1991-04-02 | Genetics Institute, Inc. | Production of procoagulant proteins |
JP2693800B2 (ja) | 1988-12-28 | 1997-12-24 | 甲府日本電気株式会社 | 浮動小数点データ総和演算回路 |
NL9000917A (nl) * | 1989-10-25 | 1991-05-16 | Holland Biotechnology | Farmaceutisch preparaat met endoproteolytische activiteit; werkwijze voor endoproteolytische processing van (precursor) eiwitten en voor de (micro) biologische bereiding van eiwitten. |
CN1024746C (zh) * | 1989-12-20 | 1994-06-01 | 李清祈 | 具热能调节作用构件的煮器 |
WO1992009698A1 (en) * | 1990-11-26 | 1992-06-11 | Genetics Institute, Inc. | Expression of pace in host cells and methods of use thereof |
US5780285A (en) * | 1995-03-03 | 1998-07-14 | Genentech, Inc. | Subtilisin variants capable of cleaving substrates containing dibasic residues |
AU2002255732B2 (en) | 2001-03-14 | 2006-03-09 | Eli Lilly And Company | Fluorinated trienes and their use as RXR modulators |
-
1991
- 1991-11-26 WO PCT/US1991/008725 patent/WO1992009698A1/en active IP Right Grant
- 1991-11-26 IE IE410291A patent/IE914102A1/en not_active IP Right Cessation
- 1991-11-26 JP JP50154992A patent/JP4236698B2/ja not_active Expired - Lifetime
- 1991-11-26 ES ES92901535T patent/ES2109336T3/es not_active Expired - Lifetime
- 1991-11-26 CA CA002096418A patent/CA2096418C/en not_active Expired - Lifetime
- 1991-11-26 DE DE69127829T patent/DE69127829T2/de not_active Expired - Lifetime
- 1991-11-26 EP EP92901535A patent/EP0574402B2/de not_active Expired - Lifetime
- 1991-11-26 AT AT92901535T patent/ATE158816T1/de not_active IP Right Cessation
- 1991-11-26 DK DK92901535.2T patent/DK0574402T3/da active
- 1991-11-26 EP EP96119683A patent/EP0785273A1/de not_active Withdrawn
-
1992
- 1992-05-20 US US07/885,972 patent/US5460950A/en not_active Expired - Lifetime
-
1995
- 1995-06-07 US US08/480,382 patent/US5986079A/en not_active Expired - Lifetime
-
1996
- 1996-11-08 US US08/745,880 patent/US5965425A/en not_active Expired - Fee Related
-
2008
- 2008-03-14 JP JP2008066877A patent/JP2008194050A/ja not_active Withdrawn
Also Published As
Publication number | Publication date |
---|---|
EP0574402A1 (de) | 1993-12-22 |
CA2096418C (en) | 2001-11-20 |
EP0785273A1 (de) | 1997-07-23 |
JP4236698B2 (ja) | 2009-03-11 |
US5986079A (en) | 1999-11-16 |
EP0574402A4 (en) | 1994-08-24 |
ATE158816T1 (de) | 1997-10-15 |
EP0574402B2 (de) | 2012-08-01 |
CA2096418A1 (en) | 1992-05-27 |
US5965425A (en) | 1999-10-12 |
IE914102A1 (en) | 1992-06-03 |
DE69127829T2 (de) | 1998-03-19 |
DK0574402T3 (da) | 1998-05-18 |
EP0574402B1 (de) | 1997-10-01 |
JP2008194050A (ja) | 2008-08-28 |
WO1992009698A1 (en) | 1992-06-11 |
JPH06504435A (ja) | 1994-05-26 |
US5460950A (en) | 1995-10-24 |
ES2109336T3 (es) | 1998-01-16 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
DE69127829T2 (de) | Expression von pace in wirtszellen und verfahren zu dessen verwendung | |
DE3786592T3 (de) | Transformation von Trichoderma. | |
ATE79403T1 (de) | Herstellung von thrombin-inhibitoren. | |
ATE140962T1 (de) | Dns-klone von menschlichem thrombomodulin | |
NZ239357A (en) | Human mk gene and protein sequence | |
DE3683512D1 (de) | Verfahren zur optischen isomerisierung von optisch aktiver aminosaeure und verfahren zur herstellung von optisch aktiver aminosaeure. | |
FR2607517B2 (fr) | Vecteurs d'expression de variants de l'hirudine dans les levures, procede et produit obtenu | |
ATE26986T1 (de) | Verfahren zur loesung von peptiden und proteinen, hierdurch erhaltene loesungen und deren verwendung. | |
WO1994025590A3 (en) | Trichohyalin and transglutaminase-3 and methods of using same | |
DE69430975D1 (de) | Verfahren zur Herstellung von Proteinen | |
EP0271964A3 (en) | Method for preparing protein hydrolysates soluble in an acid environment, and the hydrolysates obtained | |
DE3667802D1 (de) | Verfahren zur elektrochemischen oxydation von alkylpyridinen. | |
DE3783425D1 (de) | Mikroorganismen, die fremdproteinenthaltende pili tragen, isolierte pili, verfahren zur ausscheidung von proteinen in verwendung dieser pili und deren nutzen. | |
DE3670308D1 (de) | Enzym, verfahren zu dessen gewinnung und verwendung zur herstellung von n-(l-aspartyl-1)l-phenylalaninmethylester. | |
DE3677851D1 (de) | Verfahren zur steigerung der produktion von rekombinantem protein in hefearten der gattung saccharomyces. | |
AT385517B (de) | Verfahren zur gewinnung von proteinhaeltigen mikroorganismenzellen | |
FI934079A (fi) | Menetelmä fuusioproteiinin valmistamiseksi |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
8363 | Opposition against the patent | ||
8327 | Change in the person/name/address of the patent owner |
Owner name: GENETICS INSTITUTE,LLC(N.D.GES.D.STAATES DELAWARE) Owner name: CHIRON CORP. (N.D.GES.D. STAATES DELAWARE), EMERYV |
|
8327 | Change in the person/name/address of the patent owner |
Owner name: GENETICS INSTITUTE,LLC (N.D.GES.D.STAATES DELA, US Owner name: NOVARTIS VACCINES AND DIAGNOSTICS,INC.(N.D.GES, US |
|
8328 | Change in the person/name/address of the agent |
Representative=s name: DF-MP, 80333 MUENCHEN |
|
R102 | Epo decision maintaining patent in amended form now final |
Ref document number: 574402 Country of ref document: EP |
|
R102 | Epo decision maintaining patent in amended form now final |
Ref document number: 574402 Country of ref document: EP Effective date: 20120801 |